161 related articles for article (PubMed ID: 27384591)
1. Status quo of p53 in the treatment of tumors.
Guan YS; He Q; Zou Q
Anticancer Drugs; 2016 Oct; 27(9):811-8. PubMed ID: 27384591
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of tumor suppressor genes.
Morris LG; Chan TA
Cancer; 2015 May; 121(9):1357-68. PubMed ID: 25557041
[TBL] [Abstract][Full Text] [Related]
3. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
4. [p53 as a molecular target for cancer therapy].
Ishioka C; Osada M; Gamo M; Kanamaru R
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
[TBL] [Abstract][Full Text] [Related]
5. Methods for screening tumors for p53 status and therapeutic exploitation.
Tullo A; D'Erchia AM; Sbisà E
Expert Rev Mol Diagn; 2003 May; 3(3):289-301. PubMed ID: 12779005
[TBL] [Abstract][Full Text] [Related]
6. Exploiting the p53 pathway for the diagnosis and therapy of human cancer.
Lane DP
Cold Spring Harb Symp Quant Biol; 2005; 70():489-97. PubMed ID: 16869788
[TBL] [Abstract][Full Text] [Related]
7. p53-targeted cancer pharmacotherapy: move towards small molecule compounds.
Kim SH; Dass CR
J Pharm Pharmacol; 2011 May; 63(5):603-10. PubMed ID: 21492161
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific therapeutic targeting of p53 in cancer: one size does not fit all.
Vlatković N; Crawford K; Rubbi CP; Boyd MT
Curr Pharm Des; 2011; 17(6):618-30. PubMed ID: 21391912
[TBL] [Abstract][Full Text] [Related]
9. Will therapies that target tumour suppressor genes be useful in cancer treatment?
Szychot E; Brodkiewicz A; Peregud-Pogorzelski J
Adv Clin Exp Med; 2013; 22(6):861-4. PubMed ID: 24431316
[TBL] [Abstract][Full Text] [Related]
10. Targeting p53 in cancer.
Chène P
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):151-61. PubMed ID: 12678764
[TBL] [Abstract][Full Text] [Related]
11. Restoration of wild-type p53 function in human cancer: relevance for tumor therapy.
Bossi G; Sacchi A
Head Neck; 2007 Mar; 29(3):272-84. PubMed ID: 17230559
[TBL] [Abstract][Full Text] [Related]
12. p53 Replacement Therapy for Cancer.
Tazawa H; Kagawa S; Fujiwara T
Recent Results Cancer Res; 2016; 209():1-15. PubMed ID: 28101684
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53: tumors can't stand it.
Kastan MB
Cell; 2007 Mar; 128(5):837-40. PubMed ID: 17350571
[TBL] [Abstract][Full Text] [Related]
14. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract][Full Text] [Related]
15. Implications of the p53 tumor-suppressor gene in clinical oncology.
Chang F; Syrjänen S; Syrjänen K
J Clin Oncol; 1995 Apr; 13(4):1009-22. PubMed ID: 7707100
[TBL] [Abstract][Full Text] [Related]
16. Targeting p53 for enhanced radio- and chemo-sensitivity.
Lu C; El-Deiry WS
Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822
[TBL] [Abstract][Full Text] [Related]
17. [Study of the molecular mechanisms controlling activity of protein p53 in the development of new strategies in cancer therapeutics].
Marine Ch
Bull Mem Acad R Med Belg; 2009; 164(5-6):175-80; discussion 180-1. PubMed ID: 20666148
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
Selivanova G; Wiman KG
Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
[TBL] [Abstract][Full Text] [Related]
19. P53 tumor suppressor gene therapy for cancer.
Nielsen LL; Maneval DC
Cancer Gene Ther; 1998; 5(1):52-63. PubMed ID: 9476967
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated p53 gene therapy for human cancer.
Fujiwara T; Kataoka M; Tanaka N
Mol Urol; 2000; 4(2):51-4. PubMed ID: 12006242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
